Carl O’Donnell
Carl O’Donnell
CRITIC
img-contested
N/A
0 reviews
PUBLIC
img-contested
N/A
0 reviews

RECENT ARTICLES

Sort by:
No Rating
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

By , (Reuters) - Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.There were no cases of severe illness or deaths among those who got the vaccine, the company said, in a sign that it could stop the worse effects of new variants that have cropped up.The vaccine was 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom,...

March 11, 2021
Share
Save
Review
No Rating
Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial

By , (Reuters) - Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval.There were no cases of severe illness or deaths among those who got the vaccine, the company said, in a sign that it could stop the worse effects of new variants that have cropped up.The vaccine was 86% effective in protecting against the more contagious virus variant first discovered and now prevalent in the United Kingdom,...

March 11, 2021
Share
Save
Review
No Rating
Pfizer says it has second doses of COVID-19 shot on hand, expects no U.S. supply problems

Pfizer says it has second doses of COVID-19 shot on hand, expects no U.S. supply problems

By (Reuters) - Pfizer Inc has been holding on to second doses for each of its COVID-19 vaccinations at the request of the federal government and anticipates no problems supplying them to Americans, a spokeswoman said in a statement on Friday.Pfizer’s comments run counter to a report in the Washington Post that the federal government ran down its vaccine reserve in late December and has no remaining reserves of doses on hand.“Operation Warp Speed has asked us to start shipping second doses only recently,” the spokeswoman said. “As a result, we have on hand all the second doses of the...

January 15, 2021
Share
Save
Review
No Rating
Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

Exclusive: Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

By , NEW YORK (Reuters) - Drugmakers including Pfizer Inc, Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1, according to drugmakers and data analyzed by healthcare research firm 3 Axis Advisors.The hikes come as drugmakers are reeling from effects of the COVID-19 pandemic, which has reduced doctor visits and demand for some drugs. They are also fighting new drug price cutting rules from the Trump administration, which would reduce the industry’s profitability.The companies kept their price increases at 10% or below, and the...

+1
December 31, 2020
Share
Save
Review
No Rating
Millions of U.S. vaccine doses sit on ice, putting 2020 goal in doubt

Millions of U.S. vaccine doses sit on ice, putting 2020 goal in doubt

By , (Reuters) -Millions of COVID-19 vaccines are sitting unused in U.S. hospitals and elsewhere a week into the massive inoculation campaign, putting the government’s target for 20 million vaccinations this month in doubt.As of Wednesday morning, only 1 million shots of the Pfizer-BioNTech COVID-19 vaccine had been given, about one-third of the first shipment sent last week. Over 9.5 million doses of vaccines, including Moderna’s, have now been sent to states, according to the U.S. Centers for Disease Control and Prevention.While hospitals have started giving out Moderna’s vaccine, the CDC...

+1
December 23, 2020
Share
Save
Review
No Rating
Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

Moderna COVID-19 vaccine begins rollout as U.S. races to broaden injection campaign

By , , DETROIT/LOS ANGELES/NEW YORK (Reuters) - U.S. distribution of Moderna Inc’s COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.Amid record coronavirus infections and deaths, Moderna has already moved vaccine supplies from its manufacturing plants to warehouses operated by distributor McKesson Corp.Workers on Saturday were packing vaccines into containers and loading them on trucks, U.S. Army General Gustave Perna said during a news conference....

+1
December 19, 2020
Share
Save
Review
No Rating
U.S. states race to buy ultra cold vaccine freezers, fueling supply worries

U.S. states race to buy ultra cold vaccine freezers, fueling supply worries

By , The push reveals a lack of infrastructure to support a super cold vaccine campaign, including equipment to store millions of doses of Pfizer’s vaccine at temperatures of minus 70 degrees Celsius (minus 94°F), significantly below the standard for vaccines of 2-8 degrees Celsius (36-46°F).Some specialty freezer makers warn of months-long waits for units.It also marks widespread wariness of the advice from the CDC, which on Aug. 26 urged healthcare providers not to purchase ultra low temperature (ULT) freezers, saying it was working on solutions for Pfizer’s “very complex storage and...

+1
November 13, 2020
Share
Save
Review
No Rating
U.S. states race to buy ultra cold vaccine freezers, fueling supply worries

U.S. states race to buy ultra cold vaccine freezers, fueling supply worries

By , The push reveals a lack of infrastructure to support a super cold vaccine campaign, including equipment to store millions of doses of Pfizer’s vaccine at temperatures of minus 70 degrees Celsius (minus 94°F), significantly below the standard for vaccines of 2-8 degrees Celsius (36-46°F).Some specialty freezer makers warn of months-long waits for units.It also marks widespread wariness of the advice from the CDC, which on Aug. 26 urged healthcare providers not to purchase ultra low temperature (ULT) freezers, saying it was working on solutions for Pfizer’s “very complex storage and...

+1
November 13, 2020
Share
Save
Review
No Rating
Novavax on track to begin U.S. trial of COVID-19 vaccine this month

Novavax on track to begin U.S. trial of COVID-19 vaccine this month

By , (Reuters) - Novavax Inc said on Monday it was on track to begin a delayed U.S.-based, late-stage study of its experimental coronavirus vaccine later this month.The company also said the vaccine, NVX-CoV2373, had been given “fast-track” status from the U.S. Food and Drug Administration and that it expected data from the trial could support U.S. authorization and approval.Novavax, which is testing the vaccine in a late-stage study in the UK, last month postponed the start of its U.S. trial by roughly a month, due to delays in scaling up the manufacturing process.A handful of companies...

+1
November 9, 2020
Share
Save
Review
No Rating
AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

AstraZeneca resumes U.S. COVID-19 vaccine trial and next week J&J prepares to do same

By , , (Reuters) - AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.Slideshow The news signaled progress against the novel coronavirus that has infected more than 41 million globally, including 8 million Americans and comes 10 days before a U.S. presidential election that may hinge on plans to fight the pandemic.AstraZeneca, one of the leading vaccine developers, paused its U.S. trial on Sept. 6 after a report of a serious...

+1
October 24, 2020
Share
Save
Review
  • Total 12 items
  • 1
  • 2
OUTLETS
reuters.com

reuters.com

CRITIC
img-trusted
100%
PUBLIC
img-trusted
78%